Uterine leiomyomas are benign tumors arising from the myometrium and largely prevalent in the woman's reproductive years. The majority of women with leiomyomas either remain asymptomatic or develop symptoms gradually over time. When patients are symptomatic, the nature of their complaints is often attributable to the number, size, and/or location of their fibroids. Depending on a patient's symptomatology and reproductive plans, treatment options include expectant management, medical management (hormonal and non-hormonal), or surgical management (myomectomy or hysterectomy).

Citations

Citations to this article as recorded by  

• Analysis of Spatial Distribution Characteristics and Location Decision Factors by Logistics Facility Types in the Seoul Metropolitan Area
  Hyunsu Jung, Eunchong Park, Sugie Lee
  Journal of Korea Planning Association.2024; 59(3): 115.     CrossRef

Uterine leiomyoma is the most common type of benign tumor in women of reproductive age. This disease is rare before menarche, and its incidence decreases after menopause. Uterine leiomyoma is known to be related to hormonal changes, but the precise underlying mechanism has yet to be determined. Although it is a benign disease, the most common form of management involves surgical intervention. Uterine leiomyoma is also related to infertility and obstetric complications. Here, we present a review of the literature regarding uterine leiomyoma and discuss management of this disease.

Citations

Citations to this article as recorded by  

• Uterine cancer and ezrin expression
  Kim Yeon-Suk, Kim Tae-Hee, Lee Hae-Hyeog, Kim Heung Yeol, Jang Dahyae, Lee Arum
  Kosin Medical Journal.2016; 31(1): 5.     CrossRef